SHFC
ABBV icon

Safe Harbor Family Capital’s AbbVie ABBV Stock Holding History

Safe Harbor Family Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Sell
888
-135
-13% -$29K 0.15% 51
2026
Q1 		$222K Sell
1,023
-153
-13% -$33.9K 0.17% 46
2025
Q4 		$269K Buy
+1,176
New +$268K 0.24% 40

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Safe Harbor Family Capital's ABBV Position: Q2 2026 in Review

Safe Harbor Family Capital reduced its AbbVie (ABBV) stake by 13% in Q2 2026, selling an estimated $29K and leaving 888 shares worth $223K. The position accounts for 0.15% of the portfolio, ranked #51.

Safe Harbor Family Capital first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $269K in Q4 2025. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Safe Harbor Family Capital held 888 shares of AbbVie worth $223K as of Q2 2026.
  • Safe Harbor Family Capital sold 135 AbbVie shares in Q2 2026, an estimated $29K.
  • AbbVie made up 0.15% of Safe Harbor Family Capital's portfolio in Q2 2026, its #51 holding.
  • Safe Harbor Family Capital first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Safe Harbor Family Capital's AbbVie position peaked at $269K in Q4 2025.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Safe Harbor Family Capital's 13F filing for Q2 2026, filed 11 Aug 2026.